Skip to main content
. 2006 Jun 28;397(Pt 2):355–367. doi: 10.1042/BJ20051521

Figure 2. Transactivation function of p53 MDM2-binding site mutants.

Figure 2

Expression vectors encoding wild-type p53, p53F19A, p53F270A and p53F19A/F270A (1 μg of DNA) were transfected into H1299 cells, and the expressed proteins were examined for changes in their steady-state levels of p53 with the amount of ubiquitination products determined by immunoblotting with anti-p53 antibody (DO-1, top panel), anti-MDM2 antibody (middle panel) or anti-p21 antibody (bottom panel) as indicated.